Although multiple α-synuclein transgenic lines have been created, which mimic some aspects of PD pathology [12], no studies have been reported on how the lack of α-synuclein affects the progression of neurodegenerative diseases. This evidence concerns the gene SNCA and neurodegenerative disease.